Top News
Surgeons repair aortic arch aneurysm with leading-edge technique
James Isbon was the second patient in the United States and the seventh in the world to have an aneurysm, or bulge, in the aortic arch above his heart repaired in a novel and minimally invasive way.
EEG brain tests help patients overcome depression
A national research trial initiated by UT Southwestern in 2012 is generating the first set of results this year that provides an early glimpse into how such high-tech strategies may change the field of mental health.
Superbug MRSA infections less costly, but still deadly
Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.
Employees gather to celebrate UTSW's 75th anniversary
The heart of the campus was electric with the energy and palpable joy of thousands of staff, faculty, students, and friends commemorating UT Southwestern’s 75th anniversary.
Immunotherapy may offer longer life for lung cancer patients
In a New England Journal of Medicine study, the immunotherapy drug pembrolizumab was combined with chemotherapy to determine whether the dual approach was more effective than chemotherapy alone for metastatic nonsquamous non-small cell lung cancer.
UTSW genetics specialist helps mom regain her life
Jessica Hitt had a rare recessive genetic condition called N-acetylglutamate synthase deficiency.
Financial strain has major impact on health care decisions
Financial strain is the single most important factor in making health care decisions for low-income individuals, who often forgo care in favor of basic needs like food and rent, researchers in UT Southwestern’s Center for Patient-Centered Outcomes Research (PCOR) found.
Potential new strategy to target skin diseases like psoriasis
Research at UT Southwestern has shown that targeting metabolism in growing cells holds promise for the treatment of skin diseases like psoriasis that are characterized by skin overgrowth resulting from excess cell division, known as hyperproliferation.
UT Southwestern experts help paralyzed college student walk again
Two years ago, a rare autoimmune disease robbed 21-year-old Kiara Connley of her vision and the ability to walk. Today, she is making amazing progress in her recovery, after UT Southwestern neurologists identified what others missed. Watch video.
Get news releases in your inbox.
Social Stories
Follow Us on social media- Juicer Feed (Facebook and Instagram)
UTSW in the News
View All UTSW in the NewsAggressive isn't always better when it comes to breast cancer
We've probably treated too many women for too long with too many drugs," said Dr. Carlos L. Arteaga, director of the Harold C. Simmons Comprehensive Cancer Center.
Watch this heart transplant surgery with a 360-degree view
UT Southwestern posted a five-minute video of a heart transplant from beginning to end. They filmed the entire thing with those 360-degree cameras.
Cancer researchers push to relax rules for clinical trials
Eighty percent of clinical trials sponsored by the US National Cancer Institute excluded people with previous cancer diagnoses.
Lurie Prize in biomedical sciences
The sixth annual Lurie Prize in Biomedical Sciences is presented to Zhijian “James” Chen, Ph.D., Professor of Molecular Biology at UT Southwestern.
More Health and Science News
View All Selected Health and Science NewsWhat’s the healthiest way to make popcorn?
“Anytime you burn fats or oils, you run the risk of creating chemical compounds that potentially can cause oxidative damage to cells,” says Lona Sandon.
How CRISPR works, explained in two minutes
You can find our latest visual attempt to wrangle the genetic complexities of CRISPR into lively, and hopefully enjoyable, two minutes.
Economic impact of medical schools and teaching hospitals
U.S. medical schools and teaching hospitals represented by the AAMC support over 6.3 million jobs in the United States.
Unnecessary exclusions shut patients out of clinical trials
Unfortunately, many sick patients are being denied the opportunity to test new drugs that might save their lives. It’s time for this to change.